These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

483 related articles for article (PubMed ID: 27187452)

  • 1. Gut Microbiota and Metabolic Health: The Potential Beneficial Effects of a Medium Chain Triglyceride Diet in Obese Individuals.
    Rial SA; Karelis AD; Bergeron KF; Mounier C
    Nutrients; 2016 May; 8(5):. PubMed ID: 27187452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating Unsaturated Fatty Acids Delineate the Metabolic Status of Obese Individuals.
    Ni Y; Zhao L; Yu H; Ma X; Bao Y; Rajani C; Loo LW; Shvetsov YB; Yu H; Chen T; Zhang Y; Wang C; Hu C; Su M; Xie G; Zhao A; Jia W; Jia W
    EBioMedicine; 2015 Oct; 2(10):1513-22. PubMed ID: 26629547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Physiological patterns of intestinal microbiota. The role of dysbacteriosis in obesity, insulin resistance, diabetes and metabolic syndrome].
    Halmos T; Suba I
    Orv Hetil; 2016 Jan; 157(1):13-22. PubMed ID: 26708682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic Health Is More Important than Obesity in the Development of Nonalcoholic Fatty Liver Disease: A 4-Year Retrospective Study.
    Lee MK; Rhee EJ; Kim MC; Moon BS; Lee JI; Song YS; Han EN; Lee HS; Son Y; Park SE; Park CY; Oh KW; Park SW; Lee WY
    Endocrinol Metab (Seoul); 2015 Dec; 30(4):522-30. PubMed ID: 26394730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apple-Derived Pectin Modulates Gut Microbiota, Improves Gut Barrier Function, and Attenuates Metabolic Endotoxemia in Rats with Diet-Induced Obesity.
    Jiang T; Gao X; Wu C; Tian F; Lei Q; Bi J; Xie B; Wang HY; Chen S; Wang X
    Nutrients; 2016 Feb; 8(3):126. PubMed ID: 26938554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A polyphenol-rich cranberry extract protects from diet-induced obesity, insulin resistance and intestinal inflammation in association with increased Akkermansia spp. population in the gut microbiota of mice.
    Anhê FF; Roy D; Pilon G; Dudonné S; Matamoros S; Varin TV; Garofalo C; Moine Q; Desjardins Y; Levy E; Marette A
    Gut; 2015 Jun; 64(6):872-83. PubMed ID: 25080446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The gut microbiota, obesity and insulin resistance.
    Shen J; Obin MS; Zhao L
    Mol Aspects Med; 2013 Feb; 34(1):39-58. PubMed ID: 23159341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The role of oils containing triacylglycerols and medium-chain fatty acids in the dietary treatment of obesity. The effect on resting energy expenditure and serum lipids].
    Hainer V; Kunesová M; Stich V; Zák A; Parizková J
    Cas Lek Cesk; 1994 Jun; 133(12):373-5. PubMed ID: 8069895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice.
    Cani PD; Bibiloni R; Knauf C; Waget A; Neyrinck AM; Delzenne NM; Burcelin R
    Diabetes; 2008 Jun; 57(6):1470-81. PubMed ID: 18305141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Divergent metabolic outcomes arising from targeted manipulation of the gut microbiota in diet-induced obesity.
    Murphy EF; Cotter PD; Hogan A; O'Sullivan O; Joyce A; Fouhy F; Clarke SF; Marques TM; O'Toole PW; Stanton C; Quigley EM; Daly C; Ross PR; O'Doherty RM; Shanahan F
    Gut; 2013 Feb; 62(2):220-6. PubMed ID: 22345653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut microbiota and metabolic syndrome.
    Festi D; Schiumerini R; Eusebi LH; Marasco G; Taddia M; Colecchia A
    World J Gastroenterol; 2014 Nov; 20(43):16079-94. PubMed ID: 25473159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prebiotic effects: metabolic and health benefits.
    Roberfroid M; Gibson GR; Hoyles L; McCartney AL; Rastall R; Rowland I; Wolvers D; Watzl B; Szajewska H; Stahl B; Guarner F; Respondek F; Whelan K; Coxam V; Davicco MJ; Léotoing L; Wittrant Y; Delzenne NM; Cani PD; Neyrinck AM; Meheust A
    Br J Nutr; 2010 Aug; 104 Suppl 2():S1-63. PubMed ID: 20920376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Causality of small and large intestinal microbiota in weight regulation and insulin resistance.
    Scheithauer TP; Dallinga-Thie GM; de Vos WM; Nieuwdorp M; van Raalte DH
    Mol Metab; 2016 Sep; 5(9):759-70. PubMed ID: 27617199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic phenotypes of obesity influence triglyceride and inflammation homoeostasis.
    Perez-Martinez P; Alcala-Diaz JF; Delgado-Lista J; Garcia-Rios A; Gomez-Delgado F; Marin-Hinojosa C; Rodriguez-Cantalejo F; Delgado-Casado N; Perez-Caballero AI; Fuentes-Jimenez FJ; Camargo A; Tinahones FJ; Ordovas JM; Perez-Jimenez F; Lopez-Miranda J
    Eur J Clin Invest; 2014 Nov; 44(11):1053-64. PubMed ID: 25231836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolically Healthy Obesity-Heterogeneity in Definitions and Unconventional Factors.
    Brandão I; Martins MJ; Monteiro R
    Metabolites; 2020 Jan; 10(2):. PubMed ID: 32012784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do nutrient-gut-microbiota interactions play a role in human obesity, insulin resistance and type 2 diabetes?
    Diamant M; Blaak EE; de Vos WM
    Obes Rev; 2011 Apr; 12(4):272-81. PubMed ID: 20804522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variable patterns of obesity and cardiometabolic phenotypes and their association with lifestyle factors in the Di@bet.es study.
    Gutiérrez-Repiso C; Soriguer F; Rojo-Martínez G; García-Fuentes E; Valdés S; Goday A; Calle-Pascual A; López-Alba A; Castell C; Menéndez E; Bordiú E; Delgado E; Ortega E; Pascual-Manich G; Urrutia I; Mora-Peces I; Vendrell J; Vázquez JA; Franch J; Girbés J; Castaño L; Serrano-Ríos M; Martínez-Larrad MT; Catalá M; Carmena R; Gomis R; Casamitjana R; Gaztambide S
    Nutr Metab Cardiovasc Dis; 2014 Sep; 24(9):947-55. PubMed ID: 24984822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Depressive symptoms, anxiety and well-being among metabolic health obese subtypes.
    Phillips CM; Perry IJ
    Psychoneuroendocrinology; 2015 Dec; 62():47-53. PubMed ID: 26232649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of endotoxemia on the molecular mechanisms of insulin resistance.
    Boroni Moreira AP; de Cássia Gonçalves Alfenas R
    Nutr Hosp; 2012; 27(2):382-90. PubMed ID: 22732959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intestinal microbiota and obesity.
    Blaut M; Klaus S
    Handb Exp Pharmacol; 2012; (209):251-73. PubMed ID: 22249818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.